Download full-text PDF

Source
http://dx.doi.org/10.1177/0891988710375213DOI Listing

Publication Analysis

Top Keywords

invited reply
4
reply ''the
4
''the death
4
death knoll
4
knoll mmse
4
mmse outlived
4
outlived purpose?''
4
invited
1
''the
1
death
1

Similar Publications

Background: The fecal immunochemical test for hemoglobin (FIT) is now a widely used non-invasive test in population-based organized screening programs for colorectal neoplasia. The positivity thresholds of tests currently in use are based on the fecal hemoglobin concentration (f-Hb), but the rationale for the adopted thresholds are not well documented. To understand current global usage of FIT in screening programs we conducted an international survey of the brands of FIT used, the f-Hb positivity threshold applied and the rationale for the choice.

View Article and Find Full Text PDF

Background: Myopia is a growing healthcare concern worldwide. Increasing evidence suggests that sleep and circadian rhythms may be associated with myopia. Furthermore, the risk factors of myopia have not been studied in the Estonian population to date.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines current practices of immediate sequential bilateral cataract surgery (ISBCS) among Italian ophthalmologists and their future attitudes toward it.
  • A multicenter survey was conducted with 246 of 2300 invited participants, revealing that 63.4% perform ISBCS, mostly on an occasional basis, with over half interested in making it routine.
  • The main advantages for ISBCS were identified as procedure efficiency and patient benefits, while concerns over risks like bilateral endophthalmitis and legal issues hinder broader adoption.
View Article and Find Full Text PDF

Background: The cutoff of <1% positive cells to define estrogen receptor (ER) negativity by immunohistochemistry (IHC) in breast cancer (BC) is debated. We explored the tumor immune microenvironment and gene-expression profile of patients with early-stage HER2-negative ER-low (ER 1%-9%) BC, comparing them to ER-negative (ER <1%) and ER-intermediate (ER 10%-50%) tumors.

Methods: Among 921 patients with early-stage I-III, ER ≤50%, HER2-negative BCs, tumors were classified as ER-negative (n = 712), ER-low (n = 128), or ER-intermediate (n = 81).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!